BSETrident Lifeline Ltd· Pharmaceuticals & BiotechnologyHighPositive
Announced Thu, 12 Jun, 2025 · 09:26 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tarang Nathabhai Gajera & PACs

Promoter Stake BuyCreeping Acquisition Near ThresholdOwnership Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.8%Reaction day
₹272.60
prior close
—
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.5%-1.3% vs market
Pharmaceuticals peers, median of 148sector-0.5%-2.4% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 2.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.8-1.5-1.3-0.5-2.4
Next day
-1.0-1.8+0.9-0.8-0.1
2d
—-1.5—-1.1—
3d
—-2.5—-2.2—
4d
-1.0-2.8+1.8-2.8+1.8
5d
—-4.6—-4.5—
1w
+0.9-4.0+4.9-4.0+4.8
15d
-1.0-0.4-0.6-1.1+0.2
1m
-2.1-0.1-2.0-0.6-1.5
2m
+2.0-4.8+6.8-4.9+6.9
3m
+4.0-2.1+6.2-2.6+6.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Tarang Nathabhai Gajera along with 12 Persons Acting in Concert (PACs) has disclosed acquisition of convertible equity warrants of Trident Lifeline Limited under a preferential offer dated June 9, 2025. The promoter group collectively held 27,02,150 shares (23.50% of paid-up capital) before this acquisition. A total of 5,93,400 warrants were acquired across the group, with the largest allocations going to Hardik Desai Family Trust (1,89,000), Amit Bhupendra Halvawala (1,39,800), and Maniya H Desai (99,000). Each warrant is convertible into one equity share of ₹10 face value, meaning the promoter group's effective stake will increase once these warrants are exercised.

Likely market impact

This signals continued promoter confidence and commitment to the company, but warrants upon conversion will dilute existing non-promoter shareholders. Investors should track future disclosures for conversion of these warrants and any further increase in promoter holding.